These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15452226)

  • 41. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
    Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
    Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.
    Groarke JM; Pevear DC
    J Infect Dis; 1999 Jun; 179(6):1538-41. PubMed ID: 10228078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
    Rossmann MG
    Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antirhinovirus activity of purine nucleoside analogs.
    De Clercq E; Bernaerts R; Bergstrom DE; Robins MJ; Montgomery JA; Holy A
    Antimicrob Agents Chemother; 1986 Mar; 29(3):482-7. PubMed ID: 3013084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of the antiviral compound MDL 20,610.
    Kenny MT; Torney HL; Dulworth JK
    Antiviral Res; 1988 Jul; 9(4):249-61. PubMed ID: 2849377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
    J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
    Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
    Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
    Conti C; Desideri N
    Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral structural proteins as targets for antivirals.
    Schlicksup CJ; Zlotnick A
    Curr Opin Virol; 2020 Dec; 45():43-50. PubMed ID: 32777753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus.
    Mousnier A; Bell AS; Swieboda DP; Morales-Sanfrutos J; Pérez-Dorado I; Brannigan JA; Newman J; Ritzefeld M; Hutton JA; Guedán A; Asfor AS; Robinson SW; Hopkins-Navratilova I; Wilkinson AJ; Johnston SL; Leatherbarrow RJ; Tuthill TJ; Solari R; Tate EW
    Nat Chem; 2018 Jun; 10(6):599-606. PubMed ID: 29760414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68.
    Sun L; Meijer A; Froeyen M; Zhang L; Thibaut HJ; Baggen J; George S; Vernachio J; van Kuppeveld FJ; Leyssen P; Hilgenfeld R; Neyts J; Delang L
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7782-5. PubMed ID: 26369972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    Hoover-Litty H; Greve JM
    J Virol; 1993 Jan; 67(1):390-7. PubMed ID: 8093221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
    Hadfield AT; Diana GD; Rossmann MG
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of a peptide inhibitor of human rhinovirus.
    Poritz MA; Malmstrom S; Schmitt A; Kim MK; Zharkikh L; Kamb A; Teng DH
    Virology; 2003 Aug; 313(1):170-83. PubMed ID: 12951031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
    Ishitsuka H; Ninomiya YT; Ohsawa C; Fujiu M; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):617-21. PubMed ID: 6295261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
    Kaiser L; Crump CE; Hayden FG
    Antiviral Res; 2000 Sep; 47(3):215-20. PubMed ID: 10974374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication.
    Wikel JH; Paget CJ; DeLong DC; Nelson JD; Wu CY; Paschal JW; Dinner A; Templeton RJ; Chaney MO; Jones ND; Chamberlin JW
    J Med Chem; 1980 Apr; 23(4):368-72. PubMed ID: 6247489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
    Diana GD; Treasurywala AM; Bailey TR; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1990 May; 33(5):1306-11. PubMed ID: 2158559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.